Drugs & Pharmaceuticals M&A » By The Online Investor Staff, updated Fri., Jun. 9, 7:24 AM
Recent mergers and acquisitions in the Drugs & Pharmaceuticals M&A category.
| This Slide: #8 of 100 |
Slide #8. Prestige Brands — Insight Pharmaceuticals
Acquirer:
Prestige Brands (NYSE:PBH)
Acquiree:
Insight Pharmaceuticals
Details:
Prestige Brands Holdings, Inc.("Prestige" or the "Company") (NYSE:PBH) today announced that it has entered into a definitive agreement to acquire Insight Pharmaceuticals Corporation ("Insight"), a marketer and distributor of feminine care and other over-the-counter ("OTC") healthcare products, for $750 million in cash. As part of the transaction, Prestige will acquire tax attributes with a present value of approximately $100 million, which results in an effective purchase price of approximately $650 million. This transaction, combined with the Hydralyte transaction announced on April 15, 2014, is expected to result in pro forma revenues and adjusted EBITDA of approximately $800 million and $300 million, respectively for the Company in fiscal 2015.
Prestige Consumer Healthcare is a holding company. Through its subsidiaries, Co. is engaged in the development, manufacturing, marketing, sales, and distribution of over-the-counter (OTC) health and personal care products. Co. conducts its operations in two reportable segments: North American OTC Healthcare and International OTC Healthcare. Co.'s brands in the North American OTC Healthcare segment include Boudreaux's Butt Paste baby ointments with products that include various diaper rash treatments and skin protectants. Co.'s brands in the International OTC Healthcare segment include Fess nasal saline sprays and washes.
PBH SEC Filing Email Alerts Service
Open the PBH Page at The Online Investor »
|
||||||||||||||||||||||||
Open the PBH Page at The Online Investor (in a new window) »
 Free PBH Email Alerts:
Get SEC Filing Alerts Get Dividend Alerts 
|
Avg. Broker Rec.
 
|
Buy (3.33 out of 4) 46th percentile
(ranked lower than approx. 54% of all stocks covered)
Analysts' Target Price: PBH Stock Forecast Based on Zacks ABR data; powered by Xignite |
